SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-023576
Filing Date
2013-04-24
Accepted
2013-04-24 14:25:48
Documents
5
Period of Report
2013-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v342393_8k.htm 8-K 22568
2 EXHIBIT 1.1 v342393_ex1-1.htm EX-1.1 137059
3 EXHIBIT 5.1 v342393_ex5-1.htm EX-5.1 8012
4 EXHIBIT 99.1 v342393_ex99-1.htm EX-99.1 10552
6 GRAPHIC tlogo.jpg GRAPHIC 33903
  Complete submission text file 0001144204-13-023576.txt   226307
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 13779009
SIC: 2835 In Vitro & In Vivo Diagnostic Substances